Tag Archives: Medical Marijuana

NTRR Works to Enhance Management Team to Capitalize on Multi-Billion-Dollar Cannabis Opportunities

By Business Wirevia The Motley Fool

Filed under:

NTRR Works to Enhance Management Team to Capitalize on Multi-Billion-Dollar Cannabis Opportunities

SARASOTA, Fla.–(BUSINESS WIRE)– Neutra Corp. (OTCBB: NTRR) announced today that the company is seeking out potential additions to its executive management team to help explore promising new business opportunities in the fast-growing medical marijuana (MMJ) industry in the U.S.

NTRR is looking for candidates with expertise in business development as the company pursues new deals and partnerships in the technology and support side of the budding MMJ industry.

“The medical marijuana industry is growing at a lightning-fast pace in markets all over the country, and we need additional manpower to fully capitalize on that growth,” Morrissey said. “We’re making plans to visit potential targets around the country this month.”

Since 1996, 18 states and the District of Columbia have approved marijuana for medical usage, and the number is growing. Most recently, Colorado and Washington passed laws legalizing the use of marijuana. Bills to legalize medical cannabis dispensaries are now on the table in Oregon and Nevada, two states that have had MMJ laws on the books for years but currently don’t allow storefront businesses.

That means big business for companies well-positioned to capitalize on changes in legislation. Medical Marijuana, Inc. (OTC: MJNA), an industry leader, recently reported earnings of approximately $1.47 million on gross revenues of $2.40 million for the quarter ended June 30, 2012. That’s a gross revenue increase of 1,200 percent quarter-over-quarter when compared to revenue of $196,748 for the quarter that ended June 30, 2011.

Through its new Los Angeles-based MMJ subsidiary, Neutra Corp. plans to follow in the footsteps of other successful public companies, including Cannabis Science, Inc. (PINK: CBIS), Medical Marijuana Inc. and Terra Tech Corp. (PINK: TRTC), enabling technological advancements in the cultivation and processing of cannabis in approved markets.

For more information on NTRR‘s initiatives, please visit www.neutracorp.com/investors.html.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information and performance data, please visit www.neutracorp.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor …read more

Source: FULL ARTICLE at DailyFinance

NTRR Explores Technological Solutions to Supply Massive Demand for Medical Marijuana

By Business Wirevia The Motley Fool

Filed under:

NTRR Explores Technological Solutions to Supply Massive Demand for Medical Marijuana

SARASOTA, Fla.–(BUSINESS WIRE)– As the market for medical marijuana explodes in the U.S., Neutra Corp. (OTCBB: NTRR), a natural wellness solutions company, is exploring new ways to produce large, potent buds indoors, without soil, year-round, no matter the weather.

New breakthroughs and improvements to existing technology will both be needed fast to keep up with demand for high-quality medicinal buds. According to research data released last week by MMJ Business Daily, retail medical cannabis sales could hit an estimated $1.5 billion in 2013, up 15 percent from last year.

Cannabis’ long-term future in the U.S. appears even brighter: The legalization of marijuana for adult use in Colorado and Washington – coupled with the emergence of several new markets and continued overall growth on the medical side – could boost overall state-legal cannabis sales to $3 billion in 2014 and $6 billion by 2018.

Where will all of that medical-grade marijuana come from? The key to consistent production of large supplies of medical cannabis could be advanced hydroponics technology. Growing marijuana indoors, safe from insects, disease, pollution and extreme weather, is a major challenge. A great deal of tools and engineering are necessary to deliver the right amounts and types of light, water, and nutrients indoors to delicate plants accustomed to sun, rain and rich soil.

NTRR is exploring new ways to improve advanced hydroponics tech to make growing potent medical cannabis cleaner, easier, more reliable and more energy efficient.

“Researchers on the cutting edge of hydroponics are using marijuana-testing gardens to create modernized, higher-yielding marijuana nutrients systems than ever before, but these systems are hardly foolproof,” said NTRR CEO Cindy Morrissey. “We believe that the first company to successfully market a simple, turn-key system for indoor cultivation stands to profit immensely, which is why we’re exploring many new hydroponic innovations today.”

Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing medical marijuana sector alongside Cannabis Science Inc. (PINK: CBIS), Medical Marijuana Inc. (PINK: MJNA), HEMP Inc. (PINK: HEMP) and Growlife Inc. (PINK: PHOT).

For more information on NTRR‘s initiatives, please visit www.neutracorp.com/investors.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including …read more
Source: FULL ARTICLE at DailyFinance

NTRR Plans to Enter Booming Medical Marijuana Industry as More States Consider Legalization

By Business Wirevia The Motley Fool

Filed under:

NTRR Plans to Enter Booming Medical Marijuana Industry as More States Consider Legalization

SARASOTA, Fla.–(BUSINESS WIRE)– As more and more states relax laws restricting the use of medical marijuana, Neutra Corp. (OTCBB: NTRR), an innovator in natural solutions for living a healthier, happier life, is considering highly promising new opportunities on the technology and support side of the budding industry.

Nationwide, the tide appears to be turning in favor of medicinal cannabis. That means big business for companies well-positioned to capitalize on changes in legislation. Medical Marijuana, Inc. (OTC: MJNA), an industry leader, recently reportedearnings of approximately $1.47 million on gross revenues of $2.40 million for the quarter ended June 30, 2012. That’s a gross revenue increase of 1,200 percent quarter-over-quarter when compared to revenue of $196,748 for the quarter that ended June 30, 2011.

“The medical marijuana industry is growing at a lightning-fast pace in markets all over the country, and we need additional manpower to fully capitalize on that growth,” Morrissey said. “We’ve already made plans to visit potential targets in California and possibly Colorado before the end of April. We are investigating new methods of product delivery aimed at a broader market as well as potential partnerships with cutting-edge research and development companies with innovative ideas.”

Since 1996, 18 states and the District of Columbia have approved marijuana for medical usage, and the number is growing. Last year, Colorado and Washington passed laws legalizing the use of marijuana. Bills to legalize medical cannabis dispensaries are now on the table in Oregon and Nevada, two states that have had MMJ laws on the books for years but currently don’t allow storefront businesses. This week in New Hampshire, state representatives passed a bill in support of establishing a New Hampshire program.

Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing medical marijuana sector alongside Cannabis Science Inc. (PINK: CBIS), Medical Marijuana Inc. (PINK: MJNA), HEMP Inc. (PINK: HEMP) and Growlife Inc. (OTC: PHOT).

For more information on NTRR‘s initiatives, please visit www.neutracorp.com/investors.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information and performance data, please visit www.neutracorp.com/investors.

…read more
Source: FULL ARTICLE at DailyFinance

Medical Marijuana Subsidiary PhytoSphere Outsources Oil Production

By Rich Smith, The Motley Fool

Filed under:

On Friday, one of the first public companies to try to capitalize on the marijuana legalization wave — aptly named Medical Marijuana, announced that its 80%-owned PhytoSPHERE Systems subsidiary has entered into a transaction with hemp-extract company CannaVEST.

Specifically, PhytoSPHERE is selling certain assets to CannaVEST for $35 million, payable in cash or CannaVEST stock in five quarterly installments beginning Jan. 31 and ending Dec. 31. The assets being sold include “equipment and inventory, Web domain names, phone numbers, and all existing and pending agreements with hemp production and processing facilities,” along with the grant of a license to use PhytoSPHERE brand names and logos.

The first installment payment, transferred on Jan. 29, shows how the agreement works in practice. CannaVEST issued 900,000 shares of stock, valued at $5 each, to PhytoSPHERE. PhytoSPHERE then transferred 720,000 of these shares to MM based on MM’s 80% ownership interest in PhytoSPHERE.

PhytoSPHERE explains the logic behind the transaction as “eliminating … substantial capital commitment required by our production facilities” by shifting raw material-production assets to CannaVEST. PhytoSPHERE maintains its access to hemp-based raw materials by entering into a supply agreement whereby CannaVEST will supply it with such ingredients at “high CBD concentrate hemp oil” needed to develop, manufacture, and market its products.

The article Medical Marijuana Subsidiary PhytoSphere Outsources Oil Production originally appeared on Fool.com.

Fool contributor Rich Smith and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
obj.addEventListener(evType, fn, useCapture);
return true;
} else if (obj.attachEvent){
var r = obj.attachEvent("on"+evType, fn);
return r;
}
}

addEvent(window, "load", function(){new FoolVisualSciences();})
addEvent(window, "load", function(){new PickAd();})

var themeName = 'dailyfinance.com';
var _gaq = _gaq || [];
_gaq.push(['_setAccount', 'UA-24928199-1']);
_gaq.push(['_trackPageview']);

(function () {

var ga = document.createElement('script');
ga.type = 'text/javascript';
ga.async = …read more
Source: FULL ARTICLE at DailyFinance